Get started
Author

Jose-Ángel Pérez-Rivera

Observed names: Angel Perez-Rivera, Angel Perez‐Rivera, Angel Pérez-Rivera, J A Perez Rivera, J A Perez-Rivera, J. A. Perez Rivera, J. Angel Perez-Rivera, J. Ángel Pérez Rivera, J.A Perez-Rivera, JA Perez-Rivera, Jose A Perez-Rivera, Jose A. Perez-Rivera, Jose Angel Perez Rivera, Jose Angel Perez‐Rivera, Jose Ángel Perez-Rivera, Jose-Angel Perez-Rivera, Jose-Angel Pérez-Rivera, Jose‐Angel Perez‐Rivera, José A Pérez-Rivera, José Ángel Pérez Rivera, José Ángel Pérez-Rivera, José-Ángel Pérez-Rivera, Ángel Pérez, Ángel Pérez-Rivera, ángel Pérez
ORCID: 0000-0003-1451-1445
Observed ORCID: 0000-0003-1451-1445
OpenAlex ID: A5003976403
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction
2025 · Borja Ibanez, Roberto Latini, et al. · New England Journal of Medicine · 146
PDF
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR Group
2020 · Ana Carolina Alba, Juan Gaztañaga, et al. · Circulation Cardiovascular Imaging · 128
An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes
2017 · Oriol Alegre, Francesc Formiga, et al. · Journal of the American Medical Directors Association · 95
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
2012 · J. Labrador, L. Lopez-Anglada, et al. · Haematologica · 91
PDF
Diagnosis and Management of Malnutrition in Patients with Heart Failure
2023 · Alberto Esteban-Fernández, Rocío Villar-Taibo, et al. · Journal of Clinical Medicine · 76
PDF
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
2021 · Xavier Rossello, Sergio Raposeiras-Roubin, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 72
Risk Factors and Cardiovascular Disease in the Elderly
2022 · Pablo Díez-Villanueva, César Jiménez-Méndez, et al. · Reviews in Cardiovascular Medicine · 55
The Role of Galectin-3 and ST2 in Cardiology: A Short Review
2021 · Ana Merino-Merino, Jeronimo Gonzalez-Bernal, et al. · Biomolecules · 47
PDF
Frailty and prognosis of older patients with chronic heart failure
2022 · César Jiménez-Méndez, Pablo Díez-Villanueva, et al. · Revista Española de Cardiología (English Edition) · 36
Significance of the learning curve in left atrial appendage occlusion with two different devices
2013 · Ignacio Cruz‐Gonzalez, Angel Perez‐Rivera, et al. · Catheterization and Cardiovascular Interventions · 34
Infective Endocarditis in the Elderly: Challenges and Strategies
2022 · Carlos Bea, Sara Vela, et al. · Journal of Cardiovascular Development and Disease · 32
PDF
Fragilidad y pronóstico de los pacientes mayores con insuficiencia cardiaca
2022 · César Jiménez-Méndez, Pablo Díez-Villanueva, et al. · Revista Española de Cardiología · 30
Safety of Sacubitril/Valsartan Initiated During Hospitalization: Data from a Non-Selected Cohort
2019 · Juan Carlos López-Azor, Lourdes Vicent, et al. · ESC Heart Failure · 28
PDF
Brain natriuretic peptide levels variation after left atrial appendage occlusion
2015 · Ignacio Cruz‐Gonzalez, Jorge Palazuelos Molinero, et al. · Catheterization and Cardiovascular Interventions · 26
Sex differences in the impact of frailty in elderly outpatients with heart failure
2022 · Pablo Díez-Villanueva, César Jiménez-Méndez, et al. · Frontiers in Cardiovascular Medicine · 21
PDF
Comorbidity and Prognosis in Octogenarians with Infective Endocarditis
2022 · Jose-Angel Perez-Rivera, Carlos Armiñanzas, et al. · Journal of Clinical Medicine · 17
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)
2021 · Marcelo Sanmartín Fernández, Francisco Marín, et al. · Journal of Comparative Effectiveness Research · 17
Different impact of chronic kidney disease in older patients with heart failure according to frailty
2024 · Pablo Díez-Villanueva, César Jiménez-Méndez, et al. · European Journal of Internal Medicine · 13
Biomarkers in atrial fibrillation and heart failure with non-reduced ejection fraction: Diagnostic application and new cut-off points
2020 · Ana Merino-Merino, Ruth Saez-Maleta, et al. · Heart & Lung · 13
Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial
2025 · Sergio Raposeiras-Roubín, Emad Abu Assi, et al. · Circulation · 12
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
2023 · Alberto Esteban-Fernández, Inés Gómez-Otero, et al. · Clinical Research in Cardiology · 12
Differences According to Age in the Diagnostic Performance of Cardiac Biomarkers to Predict Frailty in Patients with Acute Heart Failure
2022 · Lara Aguilar-Iglesias, Ana Merino-Merino, et al. · Biomolecules · 12
PDF
Effect of Telomere Length on Prognosis in Men With Acute Coronary Syndrome
2013 · Jose-Angel Perez-Rivera, Pedro Pabon-Osuna, et al. · The American Journal of Cardiology · 12
Do Elderly Patients with Heart Failure and Reduced Ejection Fraction Benefit from Pharmacological Strategies for Prevention of Arrhythmic Events?
2023 · Pablo Díez-Villanueva, Cesar Jimenez-Mendez, et al. · Cardiology · 9
PDF
Fast systematic geriatric assessment in acute heart failure patients admitted in Cardiology
2023 · Lara Aguilar-Iglesias, Ana Merino-Merino, et al. · Heart & Lung · 8
Works count: 67
Citation count: 1,207
H-index: 17
I10-index: 24
Year
Topic
Type